A review of pharmacotherapy in type 2 diabetes mellitus and its possible cardiovascular risk
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2017, Vol 6, Issue 4
Abstract
Type 2 diabetes mellitus (T2DM) is characterized by multiple pathophysiologic abnormalities. With time, multiple glucose-lowering medications are commonly required to reduce and maintain plasma glucose concentrations within the normal range. T2DM individuals also are at a very high risk for microvascular and macrovascular complications and the incidence of heart attack and stroke is increased two- to three-fold compared with non-diabetic individuals. Nearly 70 % of deaths occur in diabetes due to macrovascular complications, e.g. myocardial infarction, stroke, heart failure and peripheral vascular disease. Therefore, when selecting medications to normalize glucose levels in T2DM patients, it is important that the agent does not aggravate cardiovascular risk factors (CVRFs), and ideally improves and reduces cardiovascular morbidity and mortality. OBJECTIVES: This review article focuses on the following objectives: • Mechanism of action on different cellular level of oral (Biguanides, Sulfonylureas, Meglitinides, Thiazolidinediones, Dipeptidyl peptidase-4 inhibitors (DPP4i), Sodium glucose linked transporter 2(SGLT2) inhibitors, and Alpha-glucosidase inhibitors) and injectable (Glucagon-like peptide-1(GLP-1) receptor agonists and Insulin) glucose-lowering drugs on established CVRFs and long-term studies of cardiovascular outcomes. • Correlation between the mechanisms behind the antidiabetic medication and its side effects like weight gain, weight loss, increase or decrease of HDL cholesterol, LDL cholesterol and triglycerides and its effects on cardiovascular system (CVS). • Correlation between coronary artery disease (CAD) risk factors like Hyperglycaemia, hypertension, vascular inflammatory marker (increased c-reactive protein, increased monocyte chemotactic protein-1, increased proinflammatory cytokines),coagulation and thrombotic markers(like decrease antioxidant status, increased von willebrand factor etc..) and endothelial dysfunctions( decreased vascular reactivity, increased degradation of nitric oxide etc.) • Selection of different antidiabetic agents based on patient’s physiological conditions and its possible risk factors to prevent CVD(cardiovascular disease) Keywords: pharmacotherapy, coronary artery disease, type 2 diabetes mellitus, dyslipidemia, vascular inflammation, CVRFs.
Authors and Affiliations
Dilli Ram Thanait
Keywords
Related Articles
- EP ID EP417892
- DOI -
- Views 109
- Downloads 0
Interaction of tau proteins and orexin receptors in dementia and allied syndromes
The neuronal and neurobiological basis of cognitive dysfunction accompanying neurodegenerative processes forms an important focal point of research interest in neuroscience. The so-called‚ mild cognitive impairment refer...
A comparative review on “Rauwolfia Serpentina” for antihypertensive potential in modern medicine.
Rauwolfia serpentina is a medicinal shrub in the milkweed family. It particularly belongs to India, though its name refers to a 16th century German botanist and physician, Leonard Rauwolfia. This shrub is believed to hav...
RELATION OF ANTIOXIDANT STATUS AND LIPOPROTEIN (a) LEVEL IN MYOCARDIAL INFARCTION PATIENTS : A CLINICAL STUDY TO EVALUATE THE ANTIOXIDANT/ LIPOPROTEIN (a) RATIO AS A NOVEL PARAMETER TO INDICATE CARDIOVASCULAR ACCIDENT
Lipoprotein (a), a prominent marker of cardiovascular accident, was first described by Berg in 1963(3). Lipoprotein (a) [Lp(a)] has been considered as one of the distinguished signature in myocardial infarction and for...
Coxsakie B virus among type 1diabetic Sudanese children
Background: Type 1 diabetes is characterized by autoimmune destruction of pancreatic beta cells. Infection by Coxsackievirus B virus has been linked to the onset of type 1 diabetes; however its precise role has not been...
INSOMNIA WITH HOMOEOPATHY
Most people encounter sleep difficulties from time to time, often related to stress or pain. Many of these bouts get better without treatment. Unfortunately, in a significant proportion of the population, sleep problems...